An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours

C G C A Jackson, S Deva, K Bayston, B Mclaren, P Barlow, Noelyn Anne Hung, K Clarke, Eva Segelov, T.-Y Chao, M.-S Dai, H. -T Yen, D Cutler, J Zhi, W.-K Chan, M.-F R Kwan, C - T Hung

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Original languageEnglish
Number of pages2
JournalAnnals of Oncology
Volume30
Issue numberSupp 5
DOIs
Publication statusPublished - Oct 2019
EventESMO Congress (ESMO) 2019 - Barcelona, Spain
Duration: 27 Sep 20191 Oct 2019

Cite this

Jackson, C G C A ; Deva, S ; Bayston, K ; Mclaren, B ; Barlow, P ; Hung, Noelyn Anne ; Clarke, K ; Segelov, Eva ; Chao, T.-Y ; Dai, M.-S ; Yen, H. -T ; Cutler, D ; Zhi, J ; Chan, W.-K ; Kwan, M.-F R ; Hung, C - T. / An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. In: Annals of Oncology. 2019 ; Vol. 30, No. Supp 5.
@article{84be3a32f49541fea1c4a1340804cf07,
title = "An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours",
author = "Jackson, {C G C A} and S Deva and K Bayston and B Mclaren and P Barlow and Hung, {Noelyn Anne} and K Clarke and Eva Segelov and T.-Y Chao and M.-S Dai and Yen, {H. -T} and D Cutler and J Zhi and W.-K Chan and Kwan, {M.-F R} and Hung, {C - T}",
year = "2019",
month = "10",
doi = "10.1093/annonc/mdz244.039",
language = "English",
volume = "30",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "Supp 5",

}

Jackson, CGCA, Deva, S, Bayston, K, Mclaren, B, Barlow, P, Hung, NA, Clarke, K, Segelov, E, Chao, T-Y, Dai, M-S, Yen, H-T, Cutler, D, Zhi, J, Chan, W-K, Kwan, M-FR & Hung, CT 2019, 'An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours', Annals of Oncology, vol. 30, no. Supp 5. https://doi.org/10.1093/annonc/mdz244.039

An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours. / Jackson, C G C A; Deva, S; Bayston, K; Mclaren, B; Barlow, P; Hung, Noelyn Anne; Clarke, K; Segelov, Eva; Chao, T.-Y; Dai, M.-S; Yen, H. -T; Cutler, D; Zhi, J; Chan, W.-K; Kwan, M.-F R; Hung, C - T.

In: Annals of Oncology, Vol. 30, No. Supp 5, 10.2019.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TY - JOUR

T1 - An international randomized cross-over bio-equivalence study of oral paclitaxel 1 HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours

AU - Jackson, C G C A

AU - Deva, S

AU - Bayston, K

AU - Mclaren, B

AU - Barlow, P

AU - Hung, Noelyn Anne

AU - Clarke, K

AU - Segelov, Eva

AU - Chao, T.-Y

AU - Dai, M.-S

AU - Yen, H. -T

AU - Cutler, D

AU - Zhi, J

AU - Chan, W.-K

AU - Kwan, M.-F R

AU - Hung, C - T

PY - 2019/10

Y1 - 2019/10

U2 - 10.1093/annonc/mdz244.039

DO - 10.1093/annonc/mdz244.039

M3 - Meeting Abstract

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - Supp 5

ER -